Publications 2021

Sakurai M, Mori T, Kato K, Kanaya M, Mizuno S, Shiratori S, Wakayama T, Uchida N, Kobayashi H, Kubo K, Amano I, Ohta T, Miyazaki Y, Kanda J, Fukuda T, Atsuta Y, Kondo E, Adult Lymphoma Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT) (2021)
Outcome of allogeneic hematopoietic stem cell transplantation for follicular lymphoma relapsing after autologous transplantation: analysis of the Japan Society for Hematopoietic Cell Transplantation
Bone Marrow Transplant
DOI 10.1038/s41409-020-01192-8, PubMed 33514920

Publications 2020

Kanaya M, Kondo T (2020)
Diffuse alveolar hemorrhage during induction therapy for acute myeloid leukemia with inv(16)(p13.1q22)
Int J Hematol, 112 (2), 134-135
DOI 10.1007/s12185-020-02900-2, PubMed 32506319

Matsukawa T, Suto K, Kanaya M, Izumiyama K, Minauchi K, Yoshida S, Oda H, Miyagishima T, Mori A, Ota S, Hashimoto D, Teshima T, North Japan Hematology Study Group (NJHSG) (2020)
Validation and comparison of prognostic values of GNRI, PNI, and CONUT in newly diagnosed diffuse large B cell lymphoma
Ann Hematol, 99 (12), 2859-2868
DOI 10.1007/s00277-020-04262-5, PubMed 32970194

Senjo H, Hirata K, Izumiyama K, Minauchi K, Tsukamoto E, Itoh K, Kanaya M, Mori A, Ota S, Hashimoto D, Teshima T, North Japan Hematology Study Group (2020)
High metabolic heterogeneity on baseline 18FDG-PET/CT scan as a poor prognostic factor for newly diagnosed diffuse large B-cell lymphoma
Blood Adv, 4 (10), 2286-2296
DOI 10.1182/bloodadvances.2020001816, PubMed 32453838

Publications 2019

Senjo H, Kanaya M, Izumiyama K, Minauchi K, Hirata K, Mori A, Saito M, Tanaka M, Iijima H, Tsukamoto E, Itoh K, Ota S, Morioka M, Hashimoto D, Teshima T, North Japan Hematology Study Group (NJHSG) (2019)
Serum level of soluble interleukin-2 receptor is positively correlated with metabolic tumor volume on ¹⁸ F-FDG PET/CT in newly diagnosed patients with diffuse large B-cell lymphoma
Cancer Med, 8 (3), 953-962
DOI 10.1002/cam4.1973, PubMed 30790452

Publications 2018

Saito M, Miyashita K, Miura Y, Ogasawara R, Kanaya M, Izumiyama K, Mori A, Kondo T, Tanaka M, Morioka M, Tanaka S (2018)
Coexistence of primary colorectal follicular lymphoma and multiple myeloma: a case report
Int J Gen Med, 11, 363-367
DOI 10.2147/IJGM.S171387, PubMed 30254481

Saito M, Senjo H, Kanaya M, Izumiyama K, Mori A, Tanaka M, Morioka M, Ieko M (2018)
Acquired hemophilia A developing cerebral infarction 36 days after the frequent administration of bypass hemostatic agents
Hematol Rep, 10 (3), 7453
DOI 10.4081/hr.2018.7453, PubMed 30283617

Saito M, Senjo H, Kanaya M, Izumiyama K, Mori A, Tanaka M, Morioka M, Miyashita K, Ishida Y (2018)
Management consideration for patient with a large solitary fibrous tumor occupying the infratemporal fossa: A case report
Mol Clin Oncol, 8 (4), 544-548
DOI 10.3892/mco.2018.1563, PubMed 29556387

Saito M, Senjo H, Kanaya M, Izumiyama K, Mori A, Tanaka M, Morioka M, Miyashita K, Ishida Y (2018)
Late duodenal metastasis from renal cell carcinoma with newly developed malignant lymphoma: A case report
Mol Clin Oncol, 8 (4), 549-552
DOI 10.3892/mco.2018.1563, PubMed 29556388

Senjo H, Mori A, Kanaya M, Izumiyama K, Okada K, Takeyabu K, Tobioka H, Saito M, Tanaka M, Teshima T, Morioka M (2018)
[Pyothorax-associated lymphoma with the expression of Epstein-Barr virus latent genes]
Nihon Ronen Igakkai Zasshi, 55 (1), 143-147
DOI 10.3143/geriatrics.55.143, PubMed 29503358

Publications 2017

Kanaya M, Endo T, Hashimoto D, Endo S, Takemura R, Okada K, Hatanaka KC, Matsuno Y, Teshima T (2017)
Diffuse large B-cell lymphoma with a bulky mass in the cranial vault
Int J Hematol, 106 (2), 147-148
DOI 10.1007/s12185-017-2229-x, PubMed 28390034

Kanaya M, Hayashi Y, Hashimoto D, Endo T, Sugita J, Ohigashi H, Hashiguchi J, Matsukawa T, Matsuoka S, Kosugi-Kanaya M, Goto H, Onozawa M, Kahata K, Fujimoto K, Kondo T, Akizawa K, Shibuya H, Shimizu C, Teshima T (2017)
MALDI-TOF MS in post-transplant bloodstream infections: reliable identification of causative bacteria in the neutropenic phase
Bone Marrow Transplant, 52 (5), 778-780
DOI 10.1038/bmt.2016.365, PubMed 28134922

Publications 2016

Kanaya M, Shibuya K, Hirochika R, Kanemoto M, Ohashi K, Okada M, Wagatsuma Y, Cho Y, Kojima H, Teshima T, Imamura M, Sakamaki H, Shibuya A (2016)
Soluble DNAM-1, as a Predictive Biomarker for Acute Graft-Versus-Host Disease
PLoS One, 11 (6), e0154173
DOI 10.1371/journal.pone.0154173, PubMed 27257974

Kasahara K, Onozawa M, Miyashita N, Yokohata E, Yoshida M, Kanaya M, Kosugi-Kanaya M, Takemura R, Takahashi S, Sugita J, Shigematsu A, Takahata M, Fujisawa S, Hashimoto D, Fujimoto K, Endo T, Kondo T, Teshima T (2016)
Cytogenetically Unrelated Clones in Acute Myeloid Leukemia Showing Different Responses to Chemotherapy
Case Rep Hematol, 2016, 2373902
DOI 10.1155/2016/2373902, PubMed 27034857

Saito M, Kanaya M, Izumiyama K, Mori A, Irie T, Tanaka M, Morioka M, Ieko M (2016)
Treatment of bleeding in acquired hemophilia A with the proper administration of recombinant activated factor VII: single-center study of 7 cases
Int J Gen Med, 9, 393-399
DOI 10.2147/IJGM.S118422, PubMed 27843336

Publications 2014

Nabekura T, Kanaya M, Shibuya A, Fu G, Gascoigne NR, Lanier LL (2014)
Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection
Immunity, 40 (2), 225-34
DOI 10.1016/j.immuni.2013.12.011, PubMed 24440149

Publications 2012

Kanaya M, Nabekura T, Shibuya K, Shibuya A (2012)
[Critical role of activating immune receptor DNAM-1 in the development of acute GVHD]
Rinsho Ketsueki, 53 (5), 497-503
PubMed 22728551